PDE-4 Inhibitor Roflumilast and Polycystic Ovary Syndrome

NCT02037672 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

PCOS
Obesity

Interventions

DRUG: metformin
DRUG: metformin and roflumilast

Sponsor

University Medical Centre Ljubljana